COVID-19 Outbreak in France: Setup and Activities of a Mobile Extracorporeal Membrane Oxygenation Team During the First 3 Weeks.
作者信息
Haye Guillaume, Fourdrain Alex, Abou-Arab Osama, Berna Pascal, Mahjoub Yazine
机构信息
Department of Anaesthesiology and Critical Care Medicine.
Department of Thoracic Surgery, Amiens Picardy University Hospital, Amiens, France.
出版信息
J Cardiothorac Vasc Anesth. 2020 Dec;34(12):3493-3495. doi: 10.1053/j.jvca.2020.05.004. Epub 2020 May 8.
Abstract
摘要
相似文献
1
COVID-19 Outbreak in France: Setup and Activities of a Mobile Extracorporeal Membrane Oxygenation Team During the First 3 Weeks.法国的COVID-19疫情：移动体外膜肺氧合团队在前3周的组建与活动
J Cardiothorac Vasc Anesth. 2020 Dec;34(12):3493-3495. doi: 10.1053/j.jvca.2020.05.004. Epub 2020 May 8.
2
Organization of extracorporeal membrane oxygenation services for COVID-19.COVID-19 体外膜肺氧合服务的组织。
Asian Cardiovasc Thorac Ann. 2021 Mar;29(3):165-169. doi: 10.1177/0218492320962932. Epub 2020 Sep 30.
3
Percutaneous Dilatational Tracheostomy in Coronavirus Disease 2019 Extracorporeal Membrane Oxygenation Patients: A Case Series.2019冠状病毒病体外膜肺氧合患者的经皮扩张气管切开术：病例系列
J Cardiothorac Vasc Anesth. 2021 Jan;35(1):348-350. doi: 10.1053/j.jvca.2020.06.024. Epub 2020 Jun 12.
4
Outcomes of Patients Denied Extracorporeal Membrane Oxygenation during the COVID-19 Pandemic in Greater Paris, France.法国大巴黎地区新冠疫情期间被拒绝接受体外膜肺氧合治疗的患者的结局
Am J Respir Crit Care Med. 2021 Oct 15;204(8):994-997. doi: 10.1164/rccm.202105-1312LE.
5
Cardiopulmonary bypass on wheels: An evolving application of extracorporeal membrane oxygenation.轮式体外循环：体外膜肺氧合技术的不断发展应用。
J Card Surg. 2020 Dec;35(12):3658-3659. doi: 10.1111/jocs.15101. Epub 2020 Oct 10.
6
Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption.接受体外膜肺氧合和血液吸附治疗的重症新型冠状病毒肺炎患者的纵向细胞因子分析
Am J Respir Crit Care Med. 2021 Jun 1;203(11):1433-1435. doi: 10.1164/rccm.202011-4140LE.
7
ECMO during the COVID-19 pandemic: When is it justified?新型冠状病毒肺炎大流行期间的体外膜肺氧合：何时才合理？
Crit Care. 2020 Nov 19;24(1):650. doi: 10.1186/s13054-020-03386-4.
8
A Patient with COVID-19 Treated with ECMO for 26 Days.一名接受体外膜肺氧合（ECMO）治疗26天的新冠肺炎患者。
J Coll Physicians Surg Pak. 2020 Oct;30(10):171-173. doi: 10.29271/jcpsp.2020.supp2.S171.
9
Clinical data of early COVID-19 cases receiving extracorporeal membrane oxygenation in Wuhan, China.中国武汉 COVID-19 早期接受体外膜肺氧合治疗的病例的临床数据。
J Clin Anesth. 2021 Feb;68:110044. doi: 10.1016/j.jclinane.2020.110044. Epub 2020 Sep 14.
10
Contrast Echocardiography in VV-ECMO-Dependent Patients with COVID-19.新冠病毒病依赖静脉-静脉体外膜肺氧合患者的对比超声心动图
J Am Soc Echocardiogr. 2020 Nov;33(11):1419-1420. doi: 10.1016/j.echo.2020.07.012. Epub 2020 Jul 17.
引用本文的文献
1
Extracorporeal membrane oxygenation (ECMO) in patients with severe COVID-19 adult respiratory distress syndrome: a systematic review and meta-analysis.体外膜肺氧合（ECMO）用于重症新型冠状病毒肺炎成人呼吸窘迫综合征患者：一项系统评价与荟萃分析
Cardiothorac Surg. 2021;29(1):9. doi: 10.1186/s43057-021-00046-3. Epub 2021 Apr 12.
2
Relationship between the Pre-ECMO and ECMO Time and Survival of Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.体外膜肺氧合（ECMO）治疗前时间和ECMO治疗时间与重症新型冠状病毒肺炎（COVID-19）患者生存的关系：一项系统评价和荟萃分析
J Clin Med. 2024 Feb 1;13(3):868. doi: 10.3390/jcm13030868.
3
Hyperglycemia and Hypoglycemia Are Associated with In-Hospital Mortality among Patients with Coronavirus Disease 2019 Supported with Extracorporeal Membrane Oxygenation.高血糖和低血糖与接受体外膜肺氧合支持的2019冠状病毒病患者的院内死亡率相关。
J Clin Med. 2022 Aug 30;11(17):5106. doi: 10.3390/jcm11175106.
4
Implementation and Outcomes of a Mobile Extracorporeal Membrane Oxygenation Program in the United States During the Coronavirus Disease 2019 Pandemic.美国在 2019 年冠状病毒病大流行期间实施和取得的移动体外膜肺氧合计划成果。
J Cardiothorac Vasc Anesth. 2021 Oct;35(10):2869-2874. doi: 10.1053/j.jvca.2021.05.047. Epub 2021 May 26.
5
Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization.体外膜肺氧合治疗 COVID-19：体外生命支持组织 2021 年更新指南。
ASAIO J. 2021 May 1;67(5):485-495. doi: 10.1097/MAT.0000000000001422.
6
Utilization of extracorporeal membrane oxygenation during the COVID-19 pandemic.新型冠状病毒肺炎大流行期间体外膜肺氧合的应用
World J Crit Care Med. 2021 Jan 9;10(1):1-11. doi: 10.5492/wjccm.v10.i1.1.
7
Veneto's Successful Lesson for a World Shocked by COVID-19: Think Globally and Act Locally.威尼托大区给因新冠疫情而震惊的世界带来的成功经验：全球思考，本地行动。
J Cardiothorac Vasc Anesth. 2020 Sep;34(9):2346-2348. doi: 10.1053/j.jvca.2020.06.035. Epub 2020 Jun 16.
本文引用的文献
1
First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report.首例经皮心室辅助装置联合体外膜肺氧合成功治疗 2019 冠状病毒病所致难治性心原性合并血管扩张性休克：病例报告。
ASAIO J. 2020 Jun;66(6):607-609. doi: 10.1097/MAT.0000000000001178.
2
Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients.体外膜肺氧合治疗 2019 年冠状病毒病所致严重肺和心功能障碍：32 例患者的经验。
ASAIO J. 2020 Jul;66(7):722-730. doi: 10.1097/MAT.0000000000001185.
3
COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support.COVID-19 呼吸衰竭：VV-ECMO 支持下的靶向炎症治疗。
ASAIO J. 2020 Jun;66(6):603-606. doi: 10.1097/MAT.0000000000001177.
4
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China.中国上海 2019 年冠状病毒病的体外膜肺氧合治疗。
ASAIO J. 2020 May;66(5):475-481. doi: 10.1097/MAT.0000000000001172.
5
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
Zotero 插件